Emily Kilpatrick, BS
Emily’s overall research interests include investigations focused on improving quality of life in older adults. She received a Bachelor of Science degree in Physiology and Neurobiology from the University of Connecticut and spent several years as the Senior Clinical Research Coordinator for the Harvard Aging Brain Study at Massachusetts General Hospital (MGH). Her previous work at MGH focused on the preclinical and prodromal phases of Alzheimer’s Disease (AD), including the trajectory of AD pathology, associated risk factors and methods of early detection. Emily joined the Technology & Aging Lab and Geriatric Psychiatry Research Program as the Research Project Manager in February of 2019. She now provides oversight of research operations under Dr. Ipsit Vahia, Dr. Brent Forester and Dr. David Harper and manages a multi-site NIA funded clinical trial of electroconvulsive therapy for agitation and aggression in dementia (ECT-AD). She plans to continue facilitating research that contributes to innovation and improvement of clinical outcomes for physical and behavioral symptoms in older adults.